Filter
2070
Filtered Results: 2070
Text search:
afrique
Featured
Recommendations
208
New Publications
315
Language
Document type
No document type
786
Studies & Reports
439
Guidelines
293
Fact sheets
122
Manuals
91
Strategic & Response Plan
89
Infographics
62
Training Material
52
Situation Updates
40
Brochures
31
Resource Platforms
28
Online Courses
22
Videos
13
Dashboards/Maps
2
Countries / Regions
South Africa
438
Africa
360
West and Central Africa
194
Middle East and North Africa
185
East and Southern Africa
149
Senegal
118
Congo, Democratic Republic of
108
Burkina Faso
80
Yemen
64
Syria
63
Benin
59
Global
57
Guinea
43
South Sudan
43
Cameroon
37
Mali
36
Central African Republic
36
Latin America and the Carribbean
25
Niger
24
Côte d’Ivoire / Ivory Coast
21
Nigeria
20
Haiti
20
Mozambique
19
Madagascar
19
South–East Asia Region
19
India
16
Kenya
16
Southern Africa
16
Chad
15
China
15
Rwanda
15
Angola
14
Russia
14
Liberia
13
Uganda
13
Sudan
13
Sierra Leone
12
Ethiopia
12
Western and Central Europe
12
Ghana
11
Togo
11
Lebanon
10
Eastern Europe and Central Asia
10
Indonesia
9
Vietnam
9
Somalia
8
Ukraine
8
Asia
8
Zimbabwe
7
Malawi
7
Morocco
6
Saudi Arabia
6
Tanzania
6
Thailand
6
Brazil
6
Guinea-Bissau
5
Nepal
5
Iraq
5
Afghanistan
5
Zambia
5
Malaysia
5
Portugal
5
Philippines
4
Jordan
4
Turkey
4
Egypt
4
Bangladesh
4
Namibia
4
Burundi
4
Botswana
4
Gabon
4
Japan
4
Tunisia
4
Cambodia
3
Eswatini/ Swaziland
3
Libya
3
Lesotho
3
Western Pacific Region
3
Eastern Europe
3
France
3
USA
2
Germany
2
Argentina
2
Serbia
2
Hungary
2
Colombia
2
Venezuela
2
Palestine
2
Congo-Brazzaville
2
Iran
2
Kyrgyzstan
2
Denmark
2
Spain
2
South Korea
2
Pakistan
1
Mauritania
1
North Macedonia
1
Croatia
1
Ecuador
1
Greece
1
Mexico
1
Myanmar / Burma
1
Sri Lanka
1
Poland
1
Italy
1
Mongolia
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Georgia
1
North America
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Norway
1
Algeria
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
1089
Public Health
154
Clinical Guidelines
149
Women & Child Health
93
Key Resources
52
Capacity Building
31
Pharmacy & Technologies
21
Toolboxes
COVID-19
403
NCDs
116
Ebola
107
HIV
101
Mental Health
93
Rapid Response
85
NTDs
83
Caregiver
71
Disability
61
TB
57
AMR
54
Planetary Health
44
Pharmacy
25
Refugee
24
Zika
18
Conflict
16
Global Health Education
14
Cholera
13
Social Ethics
11
Polio
8
Natural Hazards
8
Health Financing Toolbox
6
Specific Hazards
1
Human schistosomiasis otherwise called bilharzia, is a fresh- water snail transmitted intravascular debilitating disease resulting from infection by the parasitic dimorphic Schistosoma trematode worms, which lives in the bloodstream of humans. The World Health Organization (WHO) regards the disease ...
After five consecutive below-average rains, the humanitarian crisis in the Horn of Africa is expanding and deepening.
Combined with insecurity and macroeconomic volatility, the impact of the drought on food and nutrition security has been devastating. Across Ethiopia, Kenya and Somalia, an estima...
Schistosomiasis, commonly known as bilharzia, is an acute and chronic tropical disease caused by trematodes of the genus Schistosoma. The schistosome parasite is transmitted through a snail intermediate host with the human being the definitive host. Worldwide, schistosomiasis continues to cause a pu...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Treatment of second-stage gambiense human African trypanosomiasis relied on toxicarsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine,initially in monotherapy and more recently in combination with nifurtimox (NECT), has drasticallyimproved the pro...
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Sleeping sickness is a neglected tropical disease affecting rural communities in sub-Saharan Africa. The reduction in the number of reported cases in recent years indicates that disease transmission is under control. However, many aspects of patient management still need to be improved. Undiagnosed ...
Human African Trypanosomiasis, also known as sleeping sickness is a devastating parasitic disease. It is a neglected tropical disease affecting communities in Africa. In this video we take a look at the disease, how it presents and and ways to control it.
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and ...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
